Oklahoma 2025 2025 Regular Session

Oklahoma Senate Bill SB34 Introduced / Bill

Filed 12/17/2024

                     
 
 
Req. No. 679 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
1st Session of the 60th Legislature (2025) 
 
SENATE BILL 34 	By: Hicks 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to prescription drugs; creating the 
Access to Lifesaving Medicines Act; providing short 
title; defining terms; prohibiting certain insurers 
and pharmacy benefits managers from imposing certain 
costs; requiring certain rebates be offered to 
certain health benefit plans; establishing terms of 
prescription drug cost sharing; directing 
promulgation of rules; providing for noncodif ication; 
providing for codification; and providing an 
effective date. 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     NEW LAW     A new section of law not to be 
codified in the Oklahoma Statutes reads as fol lows: 
This act shall be known and may be cited as the “Access to 
Lifesaving Medicines Act ”. 
SECTION 2.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 697 0 of Title 36, unless there 
is created a duplication in numbering, reads as follows: 
As used in this section: 
1.  “Adjusted out-of-pocket amount” means the copayment, 
coinsurance, or other cost -sharing obligation that a health benefit   
 
 
Req. No. 679 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
plan requires an insured to pay at the point of sale for a covered 
prescription medication otherwise payable, less the pro rata portion 
of any discounts, rebates, and price concessions in connection with 
the prescription drug; 
2.  “Claim” means any bill, claim, or proof of loss made by or 
on behalf of an insured or a prov ider to a health insurer or its 
intermediary, administrator, or representativ e, with which the 
provider has a provider contract for payment for health care 
services under any health benefit plan; 
3.  “Excess cost burden” means any copayments, coinsurance, or 
other cost-sharing an insured is required to pay at the point of 
sale to receive a prescription drug or device that exceeds the 
health insurer’s or pharmacy benefits manager ’s net cost after 
applying a pro rata portion of any discounts, rebates, or 
concessions received from manufacturers, pharmacies, or other third 
parties; 
4.  “Health benefit plan” means a health benefit plan as defined 
pursuant to Section 6060.4 of Title 36 of the Oklahoma Statutes; 
5.  “Health care provider ” or “provider” means a health care 
provider as defined pursuant to Section 3090.2 of Title 63 of the 
Oklahoma Statutes; 
6.  “Health insurer” means any entity subject to the 
jurisdiction of the Insurance Department and the insurance laws and 
regulations of this state that contracts o r offers to contract to   
 
 
Req. No. 679 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
provide, deliver, arrange for, pay for, or reimburse any of the 
costs of health care services including , but not limited to, a 
health maintenance organization, a health benefit plan, or any other 
entity providing a plan of health in surance, health benefits, or 
health care services; 
7.  “Maximum allowable claim ” means the amount the health 
insurer or pharmacy benefits manager has agreed to pay a pharmacy; 
8.  “Maximum allowable cost ” means the maximum dollar amount 
that a health insurer or its intermediary will reimburse a pharmacy 
provider for a group of drug s rated as “A”, “AB”, “NR”, or “NA” in 
the most recent edition of the Approved Drug Products with 
Therapeutic Equivalence Evaluations, published by the United States 
Food and Drug Administration, or similarly rated by a nationally 
recognized reference; 
9.  “Pharmacy” means a pharmacy as defined pursuant to Section 
353.1 of Title 59 of the Oklahoma Statutes; 
10.  “Pharmacy benefits manager ” means a pharmacy benefits 
manager as defined pursuant to Section 6960 of Title 36 of the 
Oklahoma Statutes; 
11.  “Point of sale” means the transaction in which goods or 
services including, but not limited to, prescription medications, 
medical devices, and medical supplies are sold to the consumer; 
12.  “Rebate” means:   
 
 
Req. No. 679 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
a. negotiated price concessions including , but not 
limited to, base rebates and reasonable estimates of 
any price protection rebates and performance -based 
rebates that may accrue, directly or indirectly, to 
the health insurer or pharm acy benefits manager as a 
result of point-of-sale prescription medication cla ims 
processing during the coverage year from a 
manufacturer, dispensing pharmacy, or other party to 
the transaction, or 
b. reasonable estimates of any fees and other 
administrative costs that are passed through to the 
health insurer as a result of point -of-sale 
prescription medication claims processing and serve to 
reduce the health insurer ’s prescription medication 
liabilities for the coverage year; and 
13.  “Provider contract” means any contract between a health 
care provider and a health insurer, or an i nsurer’s network, 
provider panel, intermediary, or representative, relating to the 
provision of health care services. 
B.  Any health insurer or pharmacy benefits manager that issu es, 
renews, or amends a health benefit plan with prescription drug 
coverage shall not impose an excess cost burden on an insured. 
C.  When contracting with a health insurer or health benefit 
plan to administer pharmacy benefits, a pharmacy benefits manager   
 
 
Req. No. 679 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
shall offer the health benefit plan the option of extending point -
of-sale rebates to enrollees of the plan. 
D.  Prescription drug cost -sharing for an insured shall be the 
lesser of: 
1.  The applicable copayment for the prescription medication 
that would be payable in the absence of this section; 
2.  The maximum allowable cost; 
3.  The maximum allowable claim; 
4.  The adjusted out -of-pocket amount as determined pursuant to 
this section; 
5.  The amount an insured would pay for the prescription 
medication if the insured purchased it without using his or her 
health benefit plan or any other source of prescription medication 
benefits or discounts; or 
6.  The amount the pharmacy will be reimbursed for the 
prescription medication by the health insurer or pharmacy benefits 
manager. 
E.  The Insurance Commissioner shall promulgate rules to 
effectuate the provisions of this section. 
SECTION 3.  This act shall become effective November 1, 2025. 
 
60-1-679 CAD 12/17/2024 10:51:28 AM